BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Madera S, Izzo F, Chervo MF, et al. (2023) Correction: Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer. Cell Death & Disease. 14: 833 |
| Flaqué MCD, Galigniana NM, Béguelin W, et al. (2023) Retraction Note: Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy. Breast Cancer Research : Bcr. 25: 133 |
| Proietti CJ, Béguelin W, Díaz Flaqué MC, et al. (2023) Corrigendum to "Novel role of signal transducer and activator of transcription 3 as a progesterone receptor coactivator in breast cancer" [Steroids 76 (2011) 381-392]. Steroids. 200: 109312 |
| Bruni S, Mercogliano MF, Mauro FL, et al. (2023) Cancer immune exclusion: breaking the barricade for a successful immunotherapy. Frontiers in Oncology. 13: 1135456 |
| Mercogliano MF, Bruni S, Mauro FL, et al. (2023) Emerging Targeted Therapies for HER2-Positive Breast Cancer. Cancers. 15 |
| Bruni S, Mauro FL, Proietti CJ, et al. (2023) Blocking soluble TNFα sensitizes HER2-positive breast cancer to trastuzumab through MUC4 downregulation and subverts immunosuppression. Journal For Immunotherapy of Cancer. 11 |
| Madera S, Izzo F, Chervo MF, et al. (2022) Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer. Cell Death & Disease. 13: 447 |
| Mercogliano MF, Bruni S, Mauro F, et al. (2021) Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy. Cancers. 13 |
| Chervo MF, Cordo Russo RI, Petrillo E, et al. (2020) Canonical ErbB-2 isoform and ErbB-2 variant c located in the nucleus drive triple negative breast cancer growth. Oncogene |
| Madera S, Chervo MF, Chiauzzi VA, et al. (2020) Nuclear PDCD4 Expression Defines a Subset of Luminal B-Like Breast Cancers with Good Prognosis. Hormones & Cancer |